Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Nov 28, 2023
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
GlobeNewswire
Read ↗
Nov 15, 2023
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
GlobeNewswire
Read ↗
Sep 27, 2023
Femasys Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site
Femasys IR
Read ↗
Aug 3, 2023
Femasys Initiates Enrollment in Pivotal Trial of Permanent Birth Control Candidate FemBloc
Femasys IR
Read ↗
Apr 13, 2023
FemCerv®: Well-designed technology that can minimize patient discomfort
MDedge
Read ↗
Mar 30, 2023
Femasys Announces Financial Results for Year Ended December 31, 2022 and Provides Corporate Update
Femasys IR
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.